March 22, 2018 / 12:22 PM / 5 months ago

BRIEF-Teva Canada Announces Launch Of Generic Concerta For Treatment Of ADHD

March 22 (Reuters) - Teva Pharmaceutical Industries Ltd:

* ACT METHYLPHENIDATE ER® TABLETS, A GENERIC VERSION OF CONCERTA® FOR THE TREATMENT OF ADHD

* TEVA CANADA LIMITED SAYS HEALTH CANADA APPROVED ITS APPLICATION FOR (C)ACT METHYLPHENIDATE ER TABLETS Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below